Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 546301 - 546320 out of 553687 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AA06) mycophenolic acid | CELLCEPT IV 500MG/20ML INJECTION | 4X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection | GenentechUSA,Inc. |
| USA | (L04AA06) mycophenolic acid | MYFORTIC 180MG DR TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L04AA06) mycophenolic acid | MYFORTIC 180MG DR TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L04AA06) mycophenolic acid | MYFORTIC 360MG DR TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L04AA06) mycophenolic acid | MYFORTIC 360MG DR TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L04AA06) mycophenolic acid | CELLCEPT 500MG TABLETS | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection | GenentechUSA,Inc. |
| USA | (L04AA06) mycophenolic acid | CELLCEPT 500MG TABLETS | 500 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection | GenentechUSA,Inc. |
| USA | (L04AA06) mycophenolic acid | CELLCEPT 500MG TABLETS | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection | GenentechUSA,Inc. |
| USA | (L04AA06) mycophenolic acid | CELLCEPT 500MG TABLETS | 500 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection | GenentechUSA,Inc. |
| USA | (L04AA24) abatacept (adm: P) | ORENICA CLICK JECT 125MG/VI | 4X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
| USA | (L04AA24) abatacept (adm: P) | ORENICA CLICK JECT 125MG/VI | 4X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
| USA | (L04AA24) abatacept (adm: P) | ORENCIA 125MG/VIL INJ W/DISP SYRINGE | 4X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid | Bristol-MyersSquibbCompany |
| USA | (L04AA24) abatacept (adm: P) | ORENCIA 125MG/VIL INJ W/DISP SYRINGE | 4X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid | Bristol-MyersSquibbCompany |
| USA | (L04AA24) abatacept (adm: P) | ORENCIA 50MG/0.04ML PFS | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid | Bristol-MyersSquibbCompany |
| USA | (L04AA24) abatacept (adm: P) | ORENCIA 50MG/0.04ML PFS | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid | Bristol-MyersSquibbCompany |
| USA | (L04AA24) abatacept (adm: P) | ORENCIA 87.5MG/0.07ML PFS | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid | Bristol-MyersSquibbCompany |
| USA | (L04AA24) abatacept (adm: P) | ORENCIA 87.5MG/0.07ML PFS | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid | Bristol-MyersSquibbCompany |
| USA | (L04AA24) abatacept (adm: P) | ORENCIA 250MG/VIL INJ W/DISP SYRINGE | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid | Bristol-MyersSquibbCompany |
| USA | (L04AA24) abatacept (adm: P) | ORENCIA 250MG/VIL INJ W/DISP SYRINGE | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid | Bristol-MyersSquibbCompany |
| USA | (L04AA28) belatacept (adm: P) | NULOJIX 250MG,INJ | 250MG/VIAL | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | Bristol-MyersSquibbCompany |
Pages
